Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (231-240 of 481) with videos related to

Pageof 49
Sort By:
Biorxiv : the Preprint Server for Biology|August 1, 2025
Isolation of genetically diverse influenza antibodies highlights the role of IG germline gene variation and informs the design of population-comprehensive vaccine strategiesAlexandra A Fischer, Martin Corcoran, Philip J M Brouwer, et al.
Communications Biology|October 1, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesMelanie R Walker, Alexander Underwood, Kasper H Björnsson, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infectionHejun Liu, Meng Yuan, Deli Huang, et al.
Science (New York, N.Y.)|October 21, 2020
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidateSandhya Bangaru, Gabriel Ozorowski, Hannah L Turner, et al.
Journal of Virology|August 28, 2015
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein TrimersRajesh P Ringe, Anila Yasmeen, Gabriel Ozorowski, et al.
The Journal of Biological Chemistry|May 31, 2012
Partial enzymatic deglycosylation preserves the structure of cleaved recombinant HIV-1 envelope glycoprotein trimersRafael S Depetris, Jean-Philippe Julien, Reza Khayat, et al.
Communications Biology|April 12, 2022
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunitNicholas K Hurlburt, Leah J Homad, Irika Sinha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2015
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogensJean-Philippe Julien, Jeong Hyun Lee, Gabriel Ozorowski, et al.
Science (New York, N.Y.)|March 30, 2013
Rational HIV immunogen design to target specific germline B cell receptorsJoseph Jardine, Jean-Philippe Julien, Sergey Menis, et al.
Nature Communications|April 8, 2023
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimmers as HIV-1 vaccine candidatesYi-Nan Zhang, Jennifer Paynter, Aleksandar Antanasijevic, et al.
Pageof 49

Showing results (231-240 of 481) with videos related to

Sort By:
Pageof 49
Biorxiv : the Preprint Server for Biology|August 1, 2025
Isolation of genetically diverse influenza antibodies highlights the role of IG germline gene variation and informs the design of population-comprehensive vaccine strategiesAlexandra A Fischer, Martin Corcoran, Philip J M Brouwer, et al.
Communications Biology|October 1, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesMelanie R Walker, Alexander Underwood, Kasper H Björnsson, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infectionHejun Liu, Meng Yuan, Deli Huang, et al.
Science (New York, N.Y.)|October 21, 2020
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidateSandhya Bangaru, Gabriel Ozorowski, Hannah L Turner, et al.
Journal of Virology|August 28, 2015
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein TrimersRajesh P Ringe, Anila Yasmeen, Gabriel Ozorowski, et al.
The Journal of Biological Chemistry|May 31, 2012
Partial enzymatic deglycosylation preserves the structure of cleaved recombinant HIV-1 envelope glycoprotein trimersRafael S Depetris, Jean-Philippe Julien, Reza Khayat, et al.
Communications Biology|April 12, 2022
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunitNicholas K Hurlburt, Leah J Homad, Irika Sinha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2015
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogensJean-Philippe Julien, Jeong Hyun Lee, Gabriel Ozorowski, et al.
Science (New York, N.Y.)|March 30, 2013
Rational HIV immunogen design to target specific germline B cell receptorsJoseph Jardine, Jean-Philippe Julien, Sergey Menis, et al.
Nature Communications|April 8, 2023
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimmers as HIV-1 vaccine candidatesYi-Nan Zhang, Jennifer Paynter, Aleksandar Antanasijevic, et al.
Pageof 49